ReportWire

Tag: Medical Equipment/Supplies

  • GE's stock has its best year on record ahead of final breakup

    GE's stock has its best year on record ahead of final breakup

    General Electric Co. has saved its best year for its last.

    At the beginning of the second quarter, GE’s power and renewable-energy business will be spun off as GE Vernova, while its remaining business will be relaunched as GE Aerospace. That follows the conglomerate’s separation of GE HealthCare Technologies Inc.
    GEHC,
    -0.28%

    in December 2022.

    But rather than mourn the final breakup of the 150-year old company, which was co-founded by Thomas Edison, Wall Street cheered like it never had before.

    GE’s stock
    GE,
    -0.54%

    has rocketed 95.1% in 2023 as of afternoon trading Friday. That would be by far the stock’s best year on record, based on available data going back to 1972, according to Dow Jones Market Data. The next best year was 1982, when it gained 65.4%. In comparison, the S&P 500 index
    SPX
    has rallied 24.2% this year.

    Read: GE stock sees biggest rally in more than 2 years after a big earnings beat, raised outlook.

    As good as the stock’s performance has been leading up to the breakup, most analysts feel like investors still have more to gain. Keep in mind that in many cases, a company’s parts are worth more individually than they are valued as part of a whole.

    Wells Fargo’s Matthew Akers has a pre-breakup target of $144 on GE’s stock, which implies about 13% upside from current levels.

    “GE combines an attractive business with high aftermarket mix, solid management team with a clean balance sheet, L-T margin upside and built-in catalyst with the Vernova spin in early Q2,” Akers wrote.

    J.P. Morgan’s Seth Seifman said he believes the combined equity values of GE Vernova and GE Aerospace, when including the company’s equity stake in GE HealthCare, is about $149 billion. That compares with GE’s current market capitalization of about $139 billion.

    Of the 18 analysts surveyed by FactSet who cover GE, 12 are bullish and six are neutral, while there are no bears. And the average price target is $139.23, or about 9% above current levels.

    GE’s 2023 marks the culmination of a five-year turnaround for the stock engineered by current Chief Executive Larry Culp, who will remain as CEO of GE Aerospace.

    GE’s stock has nearly tripled in the five years that Larry Culp has been CEO, outperforming the S&P 500 by a wide margin.


    General Electric Co.

    The stock had suffered its worst year ever in 2018, plunging 56.6%, just after it had its fourth-worst year in 2017, when it suffered a 44.8% decline.

    Things got so bad for GE that it got booted from the Dow Jones Industrial Average
    DJIA
    in June 2018, ending a record 111-year run in the blue-chip barometer.

    Culp was named CEO in October 2018. During his tenure, GE’s stock has had only two down years. It fell 3.2% in 2020 as the COVID-19 pandemic wreaked havoc on the aerospace business, and slumped 11.3% in 2022 as spiking inflation and interest rates fueled fears that a recession was on the horizon.

    But since the end of 2018, GE’s stock has climbed 181%, while the S&P 500 has rallied 90% and the Dow has gained 61%.

    Source link

  • SmileDirectClub winds down operations — but customers are told to keep paying

    SmileDirectClub winds down operations — but customers are told to keep paying

    SmileDirectClub Inc. said late Friday it was winding down operations, effective immediately, seeming to cast its millions of customers adrift — except when it comes to their bills.

    SmileDirectClub
    SDCCQ,
    -45.32%

    said in a statement that its aligner treatment is not available to new customers. For existing customers, the company said, “we apologize for the inconvenience, but customer care support is no longer available” through its telehealth program, including periodic check-ins.

    The company did not immediately return a request for comment.

    People on the company’s SmilePay plan will need to make all payments until paid in full, the company said. SmileDirect also ended its lifetime guarantee.

    For those seeking refunds, the company said that “there will be more information to come once the bankruptcy process determines next steps and additional measures customers can take.”

    The company in late September filed for bankruptcy protection, saying it was seeking to find investors for a “comprehensive recapitalization.” In January, it laid off workers and ended a few international operations in a bid to become profitable.

    The company has long attracted criticism for its teledentistry model, which it has said aims to disrupt the orthodontics industry. There were allegations a few years ago that it had harmed customers by breaking teeth and causing nerve damage, which the company denied.

    Setbacks also include a scathing report from a short seller; regulatory action in California, Alabama and Georgia; and opposition to the company’s business practices from medical organizations including the American Dental Association and the American Association of Orthodontists.

    Source link

  • Dividend stocks are dirt cheap. It may be time to back up the truck.

    Dividend stocks are dirt cheap. It may be time to back up the truck.

    The stock market always overreacts, and this year it seems as if investors believe dividend stocks have become toxic. But a look at yields on quality dividend stocks relative to the market underlines what may be an excellent opportunity for long-term investors to pursue growth with an income stream that builds up over the years.

    The current environment, in which you can get a yield of more than 5% yield on your cash at a bank or lock in a yield of 4.57% on a10-year U.S. Treasury note
    BX:TMUBMUSD10Y
    or close to 5% on a 20-year Treasury bond
    BX:TMUBMUSD20Y
    seems to have made some investors forget two things: A stock’s dividend payout can rise over the long term, and so can it is price.

    It is never fun to see your portfolio underperform during a broad market swing. And people have a tendency to prefer jumping on a trend hoping to keep riding it, rather than taking advantage of opportunities brought about by price declines. We may be at such a moment for quality dividend stocks, based on their yields relative to that of the benchmark S&P 500
    SPX.

    Drew Justman of Madison Funds explained during an interview with MarketWatch how he and John Brown, who co-manage the Madison Dividend Income Fund, BHBFX MDMIX and the new Madison Dividend Value ETF
    DIVL,
    use relative dividend yields as part of their screening process for stocks. He said he has never seen such yields, when compared with that of the broad market, during 20 years of work as a securities analyst and portfolio manager.

    Dividend stocks are down

    Before diving in, we can illustrate the market’s current loathing of dividend stocks by comparing the performance of the Schwab U.S. Equity ETF
    SCHD,
    which tracks the Dow Jones U.S. Dividend 100 Index, with that of the SPDR S&P 500 ETF Trust
    SPY.
    Let’s look at a total return chart (with dividends reinvested) starting at the end of 2021, since the Federal Reserve started its cycle of interest rate increases in March 2022:


    FactSet

    The Dow Jones U.S. Dividend 100 Index is made up of “high-dividend-yielding stocks in the U.S. with a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios,” according to S&P Dow Jones Indices.

    The end results for the two ETFs from the end of 2021 through Tuesday are similar. But you can see how the performance pattern has been different, with the dividend stocks holding up well during the stock market’s reaction to the Fed’s move last year, but trailing the market’s recovery as yields on CDs and bonds have become so much more attractive this year. Let’s break down the performance since the end of 2021, this time bringing in the Madison Dividend Income Fund’s Class Y and Class I shares:

    Fund

    2023 return

    2022 return

    Return since the end of 2021

    SPDR S&P 500 ETF Trust

    14.9%

    -18.2%

    -6.0%

    Schwab U.S. Dividend Equity ETF

    -3.8%

    -3.2%

    -6.9%

    Madison Dividend Income Fund – Class Y

    -4.7%

    -5.4%

    -9.9%

    Madison Dividend Income Fund – Class I

    -4.7%

    -5.3%

    -9.7%

    Source: FactSet

    Dividend stocks held up well during 2022, as the S&P 500 fell more than 18%. But they have been left behind during this year’s rally.

    The Madison Dividend Income Fund was established in 1986. The Class Y shares have annual expenses of 0.91% of assets under management and are rated three stars (out of five) within Morningstar’s “Large Value” fund category. The Class I shares have only been available since 2020. They have a lower expense ratio of 0.81% and are distributed through investment advisers or through platforms such as Schwab, which charges a $50 fee to buy Class I shares.

    The opportunity — high relative yields

    The Madison Dividend Income Fund holds 40 stocks. Justman explained that when he and Brown select stocks for the fund their investible universe begins with the components of the Russell 1000 Index
    RUT,
    which is made up of the largest 1,000 companies by market capitalization listed on U.S. exchanges. Their first cut narrows the list to about 225 stocks with dividend yields of at least 1.1 times that of the index.

    The Madison team calculates a stock’s relative dividend yield by dividing its yield by that of the S&P 500. Let’s do that for the Schwab U.S. Equity ETF
    SCHD
    (because it tracks the Dow Jones U.S. Dividend 100 Index) to illustrate the opportunity that Justman highlighted:

    Index or ETF

    Dividend yield

    5-year Avg. yield 

    10-year Avg. yield 

    15-year Avg. yield 

    Relative yield

    5-year Avg. relative yield 

    10-year Avg. relative yield 

    15-year Avg. relative yield 

    Schwab U.S. Dividend Equity ETF

    3.99%

    3.41%

    3.20%

    3.16%

    2.6

    2.1

    1.8

    1.6

    S&P 500

    1.55%

    1.62%

    1.79%

    1.92%

    Source: FactSet

    The Schwab U.S. Equity ETF’s relative yield is 2.6 — that is, its dividend yield is 2.6 times that of the S&P 500, which is much higher than the long-term averages going back 15 years. If we went back 20 years, the average relative yield would be 1.7.

    Examples of high-quality stocks with high relative dividend yields

    After narrowing down the Russell 1000 to about 225 stocks with relative dividend yields of at least 1.1, Justman and Brown cut further to about 80 companies with a long history of raising dividends and with strong balance sheets, before moving further through a deeper analysis to arrive at a portfolio of about 40 stocks.

    When asked about oil companies and others that pay fixed quarterly dividends plus variable dividends, he said, “We try to reach out to the company and get an estimate of special dividends and try to factor that in.” Two examples of companies held by the fund that pay variable dividends are ConocoPhillips
    COP,
    -0.29%

    and EOG Resources Inc.
    EOG,
    +0.52%
    .

    Since the balance-sheet requirement is subjective “almost all fund holdings are investment-grade rated,” Justman said. That refers to credit ratings by Standard & Poor’s, Moody’s Investors Service or Fitch Ratings. He went further, saying about 80% of the fund’s holdings were rated “A-minus or better.” BBB- is the lowest investment-grade rating from S&P. Fidelity breaks down the credit agencies’ ratings hierarchy.

    Justman named nine stocks held by the fund as good examples of quality companies with high relative yields to the S&P 500:

    Company

    Ticker

    Dividend yield

    Relative yield

    2023 return

    2022 return

    Return since the end of 2021

    CME Group Inc. Class A

    CME,
    +0.47%
    2.04%

    1.3

    31%

    -23%

    1%

    Home Depot, Inc.

    HD,
    -0.39%
    2.79%

    1.8

    -3%

    -22%

    -25%

    Lowe’s Cos., Inc.

    LOW,
    +0.27%
    2.17%

    1.4

    3%

    -21%

    -19%

    Morgan Stanley

    MS,
    -1.54%
    4.24%

    2.7

    -3%

    -10%

    -13%

    U.S. Bancorp

    USB,
    -0.25%
    5.89%

    3.8

    -22%

    -19%

    -37%

    Medtronic PLC

    MDT,
    -4.32%
    3.62%

    2.3

    1%

    -23%

    -22%

    Texas Instruments Inc.

    TXN,
    -0.21%
    3.30%

    2.1

    -3%

    -10%

    -12%

    United Parcel Service Inc. Class B

    UPS,
    -0.16%
    4.17%

    2.7

    -8%

    -16%

    -23%

    Union Pacific Corp.

    UNP,
    +1.52%
    2.52%

    1.6

    2%

    -16%

    -15%

    Source: FactSet

    Click on the tickers for more about each company, fund or index.

    Click here for Tomi Kilgore’s detailed guide to the wealth of information available for free on the MarketWatch quote page.

    Now let’s see how these companies have grown their dividend payouts over the past five years. Leaving the companies in the same order, here are compound annual growth rates (CAGR) for dividends.

    Before showing this next set of data, let’s work through one example among the nine stocks:

    • If you had purchased shares of Home Depot Inc.
      HD,
      -0.39%

      five years ago, you would have paid $193.70 a share if you went in at the close on Oct. 10, 2018. At that time, the company’s quarterly dividend was $1.03 cents a share, for an annual dividend rate of $4.12, which made for a then-current yield of 2.13%.

    • If you had held your shares of Home Depot for five years through Tuesday, your quarterly dividend would have increased to $2.09 a share, for a current annual payout of $8.36. The company’s dividend has increased at a compound annual growth rate (CAGR) of 15.2% over the past five years. In comparison, the S&P 500’s weighted dividend rate has increased at a CAGR of 6.24% over the past five years, according to FactSet.

    • That annual payout rate of $8.36 would make for a current dividend yield of 2.79% for a new investor who went in at Tuesday’s closing price of $299.22. But if you had not reinvested, the dividend yield on your five-year-old shares (based on what you would have paid for them) would be 4.32%. And your share price would have risen 54%. And if you had reinvested your dividends, your total return for the five years would have been 75%, slightly ahead of the 74% return for the S&P 500 SPX during that period.

    Home Depot hasn’t been the best dividend grower among the nine stocks named by Justman, but it is a good example of how an investor can build income over the long term, while also enjoying capital appreciation.

    Here’s the dividend CAGR comparison for the nine stocks:

    Company

    Ticker

    Five-year dividend CAGR

    Dividend yield on shares purchased five years ago

    Dividend yield five years ago

    Current dividend yield

    Five-year price change

    Five-year total return

    CME Group Inc. Class A

    CME,
    +0.47%
    9.46%

    2.44%

    1.55%

    2.04%

    20%

    42%

    Home Depot Inc.

    HD,
    -0.39%
    15.20%

    4.32%

    2.13%

    2.79%

    54%

    75%

    Lowe’s Cos, Inc.

    LOW,
    +0.27%
    18.04%

    4.14%

    1.81%

    2.17%

    91%

    109%

    Morgan Stanley

    MS,
    -1.54%
    23.16%

    7.62%

    2.69%

    4.24%

    80%

    108%

    U.S. Bancorp

    USB,
    -0.25%
    5.34%

    3.60%

    2.78%

    5.89%

    -39%

    -26%

    Medtronic PLC

    MDT,
    -4.32%
    6.65%

    2.90%

    2.10%

    3.62%

    -20%

    -9%

    Texas Instruments Inc.

    TXN,
    -0.21%
    11.04%

    5.24%

    3.10%

    3.30%

    59%

    82%

    United Parcel Service Inc. Class B

    UPS,
    -0.16%
    12.23%

    5.56%

    3.12%

    4.17%

    33%

    56%

    Union Pacific Corp.

    UNP,
    +1.52%
    10.20%

    3.37%

    2.07%

    2.52%

    34%

    49%

    Source: FactSet

    This isn’t to say that Justman and Brown have held all of these stocks over the past five years. In fact, Lowe’s Cos.
    LOW,
    +0.27%

    was added to the portfolio this year, as was United Parcel Service Inc.
    UPS,
    -0.16%
    .
    But for most of these companies, dividends have compounded at relatively high rates.

    When asked to name an example of a stock the fund had sold, Justman said he and Brown decided to part ways with Verizon Communications Inc.
    VZ,
    -0.94%

    last year, “as we became concerned about its fundamental competitive position in its industry.”

    Summing up the scene for dividend stocks, Justman said, “It seems this year the market is treating dividend stocks as fixed-income instruments. We think that is a short-term issue and that this is a great opportunity.”

    Don’t miss: How to tell if it is worth avoiding taxes with a municipal-bond ETF

    Source link

  • Stock Plays for October: 3 to Watch, According to J.P. Morgan

    Stock Plays for October: 3 to Watch, According to J.P. Morgan

    The stock market is entering October a little battered and bruised after September’s selloff. However, that also offers opportunities and


    J.P. Morgan


    analysts have some ideas for where to invest at the start of t…

    Source link

  • SmileDirectClub’s stock plummets 85% after Chapter 11 bankruptcy filing

    SmileDirectClub’s stock plummets 85% after Chapter 11 bankruptcy filing

    SmileDirectClub Inc. shares plummeted in the extended session Friday after the company said it had voluntarily filed for Chapter 11 bankruptcy protection as founders seek to recapitalize the teeth-straightening business.

    SmileDirectClub shares SDC, which had been halted while up 0.9% in after-hours trading pending news, promptly dropped as much as 85% when trading in the stock reopened.

    The…

    Source link

  • Exor Buys 15% Stake in Philips

    Exor Buys 15% Stake in Philips

    By Joe Hoppe

    Exor and Royal Philips jointly said that they have entered a relationship agreement, with Exor picking up a 15% stake in Philips for an undisclosed sum, but worth around 2.58 billion euros ($2.82 billion).

    Investment company Exor, which holds stakes in a number of companies such as car makers Ferrari and Stellantis, said Monday that its investment is fully supportive of Dutch health-technology company Philips’ leadership, strategy and value creation potential, and gives it the ability to nominate one member to Philips’ supervisory board.

    As of Friday’s closing, Philips had a market cap of around EUR17.18 billion.

    Exor said it was committed to being a long-term minority investor, and while it doesn’t plan to buy more shares in Philips in the short-term, over time the agreement allows for Exor to increase its participation to a maximum limit of 20% of Philips’ outstanding share capital.

    “Exor’s investment in Philips, their long-term outlook and increased focus on healthcare and technology, fit well with our strategy and substantial value creation potential,” Philips Chief Executive Roy Jakobs said.

    Write to Joe Hoppe at joseph.hoppe@wsj.com

    Source link

  • Home Depot, Target, and More to Watch This Week

    Home Depot, Target, and More to Watch This Week

    Home Depot, Target, Cisco, Deere, Walmart, and More Stocks to Watch This Week

    Source link

  • Walmart, Home Depot, Meta, DocuSign, Medtronic, and More Stock Market Movers

    Walmart, Home Depot, Meta, DocuSign, Medtronic, and More Stock Market Movers


    • Order Reprints

    • Print Article


    Source link

  • Philips says it will cut 6,000 extra jobs by 2025 as it swings to a loss

    Philips says it will cut 6,000 extra jobs by 2025 as it swings to a loss

    Royal Philips NV on Monday said it will cut an extra 6,000 jobs by 2025, including around 3,000 this year, as part of a plan to improve performance and drive value creation.

    The Dutch health-technology company
    PHIA,
    +0.57%

    PHG,
    +0.59%

    –which said in October that it was cutting 4,000 jobs, or about 5% of its 80,000-strong workforce–said Monday that the simplified operating model will make it more agile and competitive, while reducing costs. The job cuts announced Monday are in addition to those outlined in October.

    Philips said that it will now focus on extracting the full value of its portfolio through a strategy of focused organic growth.

    The company made the disclosure as it reported a swing to net loss for the fourth quarter of last year amid higher costs, but said that it has seen some improvement in the period and that is taking actions to address operational challenges in an uncertain environment.

    The Dutch health-technology company–which sells products including MRI scanners and ultrasound machines–posted a net loss attributable to shareholders of 106 million euros ($170.6 million) compared with a profit of EUR157 million for the fourth quarter of 2021 and a company-compiled consensus loss of EUR16 million.

    Adjusted earnings before interest, taxes and amortization–which strips out exceptional and other one-off items–was EUR651 million compared with EUR647 million and a consensus of EUR428 million.

    The company said its performance was hit by cost inflation that was partly offset by pricing and productivity measures.

    Group sales in the period were EUR5.42 billion compared with EUR4.94 billion and a consensus of EUR5.03 billion.

    Like-for-like sales were up 3%, compared with a company-compiled forecast for a fall of 5.2%, due to improved component supplies

    Royal Philips said it now expects low-single-digit comparable sales growth and high-single-digit adjusted Ebita margin for this year.

    It has also targeted mid-single-digit comparable sales growth and a low-teens adjusted Ebita margin by 2025, and for mid-single-digit comparable sales growth and mid-to-high-teens adjusted Ebita margin beyond 2025.

    “Considering the slowing of consumer demand and a gradual improvement of the order book conversion during 2023, Philips anticipates a slow start to the year, with improvements throughout the year supported by the ongoing productivity, pricing and other actions,” it said.

    Write to Ian Walker at ian.walker@wsj.com

    The company said its performance was hit by cost inflation that was partly offset by pricing and productivity measures.

    Group sales in the period were EUR5.42 billion compared with EUR4.94 billion and a consensus of EUR5.03 billion.

    Like-for-like sales were up 3%, compared with a company-compiled forecast for a fall of 5.2%, due to improved component supplies

    Royal Philips said it now expects low-single-digit comparable sales growth and high-single-digit adjusted Ebita margin for this year.

    “Considering the slowing of consumer demand and a gradual improvement of the order book conversion during 2023, Philips anticipates a slow start to the year, with improvements throughout the year supported by the ongoing productivity, pricing and other actions,” it said.

    Write to Ian Walker at ian.walker@wsj.com

    Source link

  • Elizabeth Holmes sentenced to over 11 years in prison for Theranos crimes

    Elizabeth Holmes sentenced to over 11 years in prison for Theranos crimes

    Theranos founder and former chief executive Elizabeth Holmes was sentenced to 135 months, or over 11 years, in prison, putting an endpoint on the unraveling of a onetime vigorously hyped Silicon Valley startup that collapsed under allegations of fraud.

    The sentence, handed down from U.S. District Judge Edward Davila, came after Holmes was convicted in January of defrauding investors in the blood-testing company, which purported to have technology that could identify diseases from a pinprick of blood from the tip of a finger.

    Prior to the sentencing, Holmes had sought more lenient treatment, while prosecutors aimed for more. Holmes had requested up to 18 months in prison, along with home confinement and community service, according to The Wall Street Journal. Prosecutors sought 15 years in prison, a three-year supervised release and restitution of $800 million, the Journal said.

    Holmes had until April 27 to surrender, and 14 days to appeal the conviction, according to the Journal. Her lawyers said they would seek permission to keep her out of prison on bail, pending appeal, the Journal said.

    Founded in 2003, Theranos’ value over the years ballooned to $9 billion. But the company’s pitch of simple-to-use blood-testing technology — which attracted the likes of the Walton and Murdoch families, along with former U.S. Secretary of State Henry Kissinger — began to fall apart in 2015, after reporting from the Wall Street Journal raised questions about the claims’ veracity.

    The Securities and Exchange Commission in 2018 charged Holmes and former president Ramesh “Sunny” Balwani with what the agency called “massive fraud,” leading Holmes to give up control of the company. Criminal charges, and the company’s dissolution, followed later that year.

    Source link

  • Philips warns of 5% fall in like-for-like sales due to supply-chain woes

    Philips warns of 5% fall in like-for-like sales due to supply-chain woes

    Royal Philips NV said Wednesday that its performance for the third quarter was hurt by stronger-than-anticipated supply-chain challenges, and adopted a more pessimistic view on its sales through the end of the year.

    The Dutch health-technology company
    PHIA,
    -8.01%

    PHG,
    -0.80%

    said that it expects to record a 1.3 billion euro ($1.26 billion) impairment charge in the period. The company said that this is an impairment of goodwill of Philips Respironics, its sleep and respiratory care business, and that it is due to revisions to the business’s financial forecast.

    This compares with adjusted Ebita of EUR512 million, or 12.3% of sales, a year earlier.

    Analysts had seen the metric at EUR336 million, according to a consensus estimate provided by the company.

    Philips expects to book a EUR1.3 billion impairment charge on its sleep and respiratory care business after revising its financial forecast for the unit, it said.

    Group comparable sales for the quarter fell around 5%.

    For the last quarter of the year, Philips now expects a mid-single-digit decline in comparable sales, it said.

    In late July, Philips had guided for 6%-9% growth in comparable sales over the second half of the year.

    “Philips still expects a better second half of the year, compared to the first half of 2022. However, the company sees prolonged supply chain disruptions and a worsening macro-environment,” it said.

    The company said it expects adjusted Ebita margin to be in the range of a high single to double digit for the last quarter of the year.

    Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com and Cristina Roca at cristina.roca@wsj.com

    Source link

  • WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen

    WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen

    Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.

    The talks have been going on for a while but any agreement isn’t likely for another few weeks or more—and there may not be one.

    Source link